Recombinant Felvizumab Biosimilar antibody

Catalog No. ABIN7795109

This Humanized Monoclonal antibody specifically detects Felvizumab Biosimilar in FACS and in vivo. It exhibits reactivity toward Human.

Quick Overview for Recombinant Felvizumab Biosimilar antibody (ABIN7795109)

Target: Felvizumab Biosimilar

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Felvizumab Biosimilar, RSV Monoclonal Antibody

Characteristics: Felvizumab Biosimilar uses the same protein sequences as the therapeutic antibody felvizumab. Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method

Immunogen: RSV

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Storage: 4 °C,-20 °C

Storage Comment: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Target Details

Target: Felvizumab Biosimilar

Target Type: Biosimilar